Results 171 to 180 of about 4,133 (246)

Perioperative propranolol during robotic‐assisted radical prostatectomy: A randomised, double‐blind, placebo‐controlled, pilot trial (PeP‐RALP)

open access: yesBJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objective This study aimed to determine the feasibility and safety of administering perioperative propranolol, as an adjunct to reduce prostate cancer recurrence, in patients undergoing robotic‐assisted laparoscopic prostatectomy (RALP) for European Association of Urology (EAU) intermediate‐ or high‐risk prostate cancer.
Shivanthe Sivanesan   +14 more
wiley   +1 more source

Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the FDA Adverse Event Reporting System

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Neurological immune‐related adverse events (N‐irAEs) from immune checkpoint inhibitors (ICIs) are rare but potentially fatal. This study aimed to characterize their real‐world profile to support early detection and management.
Tao Chen   +5 more
wiley   +1 more source

From Source Code to Cost: A Multilingual, Cost‐Aware Runtime Prediction Framework for Multi‐Cloud FaaS

open access: yesConcurrency and Computation: Practice and Experience, Volume 38, Issue 17, September 2026.
ABSTRACT Predicting the runtime and cost of Function‐as‐a‐Service (FaaS) applications remains challenging in multi‐cloud environments due to variations in code complexity, workload characteristics, and provider‐specific behaviors. This paper presents an extended version of the Orama Framework that advances runtime prediction toward a multilingual and ...
Leonardo Rebouças de Carvalho   +2 more
wiley   +1 more source

Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids. [PDF]

open access: yesJ Neurochem
Øhlenschlæger MS   +16 more
europepmc   +1 more source

Does Preoperative Mixed‐Growth Urine Culture Increase the Risk of Urinary Tract Infection After Ureteroscopic Stone Treatment? A Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Ureteroscopy (URS) has emerged as a leading treatment option for urinary stones, with its usage growing from 30% to 70% over the last 20 years. Post‐URS complications, particularly infectious issues like UTIs, remain a concern, occurring in up to 25% of cases.
Khalid Elsayed Mahmoud   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy